Maternal Vaccination and Vaccine Hesitancy
- PMID: 36841594
- PMCID: PMC9956150
- DOI: 10.1016/j.pcl.2022.11.004
Maternal Vaccination and Vaccine Hesitancy
Abstract
The American College of Obstetrics and Gynecology recommends influenza vaccine annually, Tdap with each pregnancy, and COVID-19 vaccine for those not previously vaccinated or who are due for boosters. The influenza and COVID-19 vaccines are safe during pregnancy and are effective in reducing morbidity in both the pregnant person and infant. The Tdap vaccine is given primarily to protect the newborn from pertussis through transplacental antibody transfer. Methods to enhance vaccination rates include stocking and giving vaccines in the obstetric office, recommending eligible vaccines at each visit, and focusing on the health of the infant in conversations with patients.
Keywords: COVID-19 vaccine; Influenza vaccine; Prenatal care; Tdap vaccine; Vaccination; Vaccination hesitancy.
Copyright © 2022 Elsevier Inc. All rights reserved.
References
-
- ACOG committee opinion No. 741: maternal immunization Obstet Gynecol. 2018;131(6):e214–e217. - PubMed
-
- COVID-19 vaccination among pregnant people aged 18-49 years overall, by race/ethnicity, and date reported to CDC- vaccine safety datalink, United States. CDC; 2022. https://covid.cdc.gov/covid-data-tracker/#vaccinations-pregnant-women Available at: Accessed.
-
- Arnold L.D., Luong L., Rebmann T., et al. Racial disparities in U.S. maternal influenza vaccine uptake: results from analysis of pregnancy risk assessment monitoring system (PRAMS) data, 2012-2015. Vaccine. 2019;37(18):2520–2526. - PubMed
-
- Kaur R., Callaghan T., Regan A.K. Disparities in maternal influenza immunization among women in rural and urban areas of the United States. Prev Med. 2021;147:106531. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical